The management of intracranial dural arteriovenous fistulas (DAVFs) is complex and may require a combination of various treatment techniques. Endovascular embolization has recently emerged as the primary definitive treatment modality. However, an increasing body of literature has supported the use of stereotactic radiosurgery as the sole therapeutic modality or in combination with embolization and/or surgery. We review the rationale, results, and complications of stereotactic radiosurgery for intracranial DAVFs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10143-011-0315-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Spatial accuracy of dose delivery significantly impacts the planning target volume margin in linear accelerator-based intracranial stereotactic radiosurgery.
Sci Rep
January 2025
Radiation Safety and Quality Assurance division, National Cancer Center Hospital East, Chiba, 277-8577, Japan.
The impact of three-dimensional (3D) dose delivery accuracy of C-arm linacs on the planning target volume (PTV) margin was evaluated for non-coplanar intracranial stereotactic radiosurgery (SRS). A multi-institutional 3D starshot test using beams from seven directions was conducted at 22 clinics using Varian and Elekta linacs with X-ray CT-based polymer gel dosimeters. Variability in dose delivery accuracy was observed, with the distance between the imaging isocenter and each beam exceeding 1 mm at one institution for Varian and nine institutions for Elekta.
View Article and Find Full Text PDFSurvival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015-2022).
Eur J Cancer
January 2025
National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Electronic address:
Introduction: Advances in modern therapies have improved outcomes for patients with melanoma brain metastases (MBM), though prognosis remains poor. The optimal treatment strategy for patients who do not meet clinical trial inclusion criteria is unclear.
Methods: This study included all patients with MBM diagnosed in Denmark between 2015 and 2022, identified through the Danish Metastatic Melanoma Database (DAMMED) and local surgical and radiotherapy records.
Intrafraction motion in intra-cranial multi-target stereotactic radiosurgery plans: A multi-institutional investigation on robustness.
Phys Med
January 2025
Centre for Medical and Radiation Physics, University of Wollongong, NSW, Australia; St George Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia; School of Physics, University of Sydney, Camperdown, NSW, Australia.
Purpose: Even with modern immobilisation devices, some amount of intrafraction patient motion is likely to occur during stereotactic radiosurgery (SRS) delivery. The aim of this work was to investigate how robustness of plans to intrafraction motion is affected by plan geometry and complexity.
Methods: In 2018, the Trans-Tasman Radiation Oncology Group conducted a multiple-target SRS international planning challenge, the data from which was utilised in this study.
Communicating hydrocephalus following stereotactic radiosurgery for periventricular meningiomas: illustrative cases.
J Neurosurg Case Lessons
January 2025
Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, University College London Hospitals, London, United Kingdom.
Background: Stereotactic radiosurgery (SRS) is a well-established option for the management of intracranial tumors, including meningiomas. Although valued for its low invasiveness and precision, it still carries a risk of complications. Communicating hydrocephalus is a serious, albeit rarely reported, complication of SRS.
View Article and Find Full Text PDFRole of stereotactic radiosurgery for intracranial epidermoid tumors: a systematic review to assess its safety, efficacy, and complication profile.
J Neurooncol
January 2025
University of Virginia, Charlottesville, VA, USA.
Background: Even a gross total resection of a benign epidermoid tumor (ET) carries a high risk of recurrence. The management strategy mostly involves redo surgical excision but at a significant cost of morbidity and mortality. The role of adjuvant radiation therapies in this scenario is still undefined.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!